Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Docetaxel Plus Oxaliplatin (DOCOX) With or Without Cetuximab in Patients With Metastatic Gastric and/or Gastroesophageal Junction Adenocarcinoma

NCT00517829 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00517829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00517829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Docetaxel Plus Oxaliplatin (DOCOX) With or Without Cetuximab in Patients With Metastatic Gastric and/or Gastroesophageal Junction Adenocarcinoma
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2012
Enrollment
150 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer adenocarcinoma metastatic